USP18 and neoplasm: In addition to an inhibitory effect on IFN-I stimulation, USP18 deconjugates ubiquitin-like modifier ISG15 from ISGylated proteins.14,17 Therefore, we next explored whether USP18-regulated protein ISGylation in the TME contributed to this tumor-suppressive phenotype.